Rochester Drug Cooperative will stop distributing opioids amid rising legal and compliance costs, the New York-based drug distribution company said Jan. 14.
While opioids represent a relatively small percentage of the cooperative's total sales, they account for significant legal and compliance expenses, the distributor said.
"The ever-increasing expenses associated with the legal and regulatory compliance for this segment of drugs are simply not sustainable," the company wrote in a news release.
The company will continue distributing its other products and said it plans to focus more on generic drugs.
Read the full news release here.